Schedule 13G ownership disclosure

ROYALTY PHARMA PLC- CL A

Class A ordinary shares, par value US$0.0001 per share · CUSIP: G7709Q104

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • General Atlantic, L.P.

    Shares: 14,243,870.00 · Class: 3.2%

  • General Atlantic (RP) Collections, LLC

    Shares: 14,243,870.00 · Class: 3.2%

  • GA RP Holding, L.P.

    Shares: 0.00 · Class: 0.0%

  • General Atlantic Partners AIV-1 A, L.P.

    Shares: 14,243,870.00 · Class: 3.2%

  • General Atlantic Partners AIV-1 B, L.P.

    Shares: 14,243,870.00 · Class: 3.2%

  • GAP Coinvestments CDA, L.P.

    Shares: 14,243,870.00 · Class: 3.2%

  • GAP Coinvestments III, LLC

    Shares: 14,243,870.00 · Class: 3.2%

  • GAP Coinvestments IV, LLC

    Shares: 14,243,870.00 · Class: 3.2%

  • GAP Coinvestments V, LLC

    Shares: 14,243,870.00 · Class: 3.2%

  • General Atlantic (SPV) GP, LLC

    Shares: 14,243,870.00 · Class: 3.2%

  • General Atlantic GenPar, L.P.

    Shares: 14,243,870.00 · Class: 3.2%

  • General Atlantic Partners (Bermuda) EU, L.P.

    Shares: 0.00 · Class: 0.0%

  • General Atlantic Partners (Bermuda) IV, L.P.

    Shares: 0.00 · Class: 0.0%

  • General Atlantic Partners (Lux) SCSp

    Shares: 0.00 · Class: 0.0%

  • General Atlantic GenPar (Lux) SCSp

    Shares: 0.00 · Class: 0.0%

  • General Atlantic (Lux) S.a r.l.

    Shares: 0.00 · Class: 0.0%

  • General Atlantic GenPar (Bermuda), L.P.

    Shares: 0.00 · Class: 0.0%

  • GAP (Bermuda) L.P.

    Shares: 0.00 · Class: 0.0%

  • GA RP Holding, Ltd.

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950142-25-002172
Form type
SCHEDULE 13G/A
Filer
GENERAL ATLANTIC, L.P.
CIK
CIK 1017645
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub